Purchase Order 36C26121P0044
- Not listed
- This is a $1,415,722.03 firm fixed price contract awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 to RLS USA Inc., a foreign-owned for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals and related services to support nuclear medicine operations at VA medical facilities. RLS USA Inc. has received numerous federal contracts from VA and the Defense Health Agency to supply medical isotopes such...
- This is a $425,725.07 firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the supply of non-pet radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers. It has a performance period from April 1, 2025 to March 31, 2026. The contract is not a set-aside. RLS (USA) Inc. is a small business that specializes in providing...
- This is a definitive contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the supply of radiopharmaceuticals and related services. The $878,999.37 firm-fixed price contract is not set aside and has an ultimate completion date of September 17, 2024. RLS (USA) Inc. specializes in providing a wide range of molecular imaging products, including medical isotopes and radiopharmaceuticals, to support nuclear medicine...
- This contract award is for the delivery of non-pet radiopharmaceuticals to the Palo Alto VA Medical Center. The prime contractor is RLS USA Inc., a foreign-owned, for-profit radiopharmacy company that specializes in supplying radiopharmaceuticals and related services to the U.S. federal government, particularly the Department of Veterans Affairs (VA) and Defense Health Agency. The contract has a ceiling value of $134,376.90 and is a firm-fixed price delivery order with a performance period...
- This federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is for the provision of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). The $833,285.36 firm fixed-price purchase order has a performance period ending on June 22, 2023. RLS (USA) Inc. is a small business that specializes in supplying critical molecular imaging products, including medical isotopes and radiopharmaceuticals, to support nuclear...
- This is a firm-fixed price purchase order awarded to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 7 (VISN 7). The contract, valued at $440,764.00, is for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate to support nuclear medicine diagnostic services at VA medical centers. The award is designated as a total...
- This firm-fixed price federal contract award, valued at $425,794.77, was issued by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals and related services to support nuclear medicine diagnostic procedures at VA medical centers and military treatment facilities over a 6-month period ending in July 2024. RLS (USA) Inc. operates a nationwide network of 31 radiopharmacy facilities,...
- This is a federal contract award to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA). The contract is for the supply of radiopharmaceuticals and related supplies, with a ceiling value of $179,605.38 and a performance period through March 31, 2026. RLS (USA) Inc. is an established federal contractor, holding multiple Indefinite Delivery Vehicles (IDVs) with the VA and...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $607,676.91 firm fixed price delivery order contract to RLS USA Inc., a foreign-owned for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals, such as gallium-67, fluorodeoxyglucose F-18, thallium-201, and technetium-99m, to support nuclear medicine services at the Milwaukee VA Medical Center. This delivery order contract is likely part of a...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, was awarded a $1.13 million firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 22 on December 1, 2023, with performance extending through November 30, 2026. The contract, which carries no set-aside designation, calls for the supply of radiopharmaceutical products to support nuclear medicine diagnostic and therapeutic imaging services. The...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to foreign-owned, for-profit radiopharmacy RLS USA Inc. The contract, valued at $146,279.55, is for the provision of non-PET radiopharmaceuticals and related supplies to support nuclear medicine services at the VA Palo Alto Health Care System. The original solicitation was a request for quote (RFQ) issued by the VA Network Contracting Office 21 (NCO 21) and did not utilize any set-aside designation. RLS USA Inc. is a large radiopharmacy company that has received numerous federal contract awards from the VA and Defense Health Agency to supply various radiopharmaceuticals, including isotopes like gallium-67, fluorodeoxyglucose F-18, and technetium-99m, to meet the needs of VA medical centers and military treatment facilities.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--NON PET Radiopharmaceuticals | 36C26120Q0428 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 | Solicitation 2/2 | 9/25/20, 7:36 PM | |
6505--NON PET Radiopharmaceuticals | 36C26120Q0428 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 | Pre-Solicitation 1/2 | 9/25/20, 5:14 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($81k) | 9/26/22 | |
| Not listed | Not listed | $227.4k | 10/1/20 |